Who owns Franklin Templeton Etf Tr genomic adv etf?
- Ticker: HELX
- CUSIP Number: 35473p520
Tip: Access positions for across all investors
Analyze quarterly positions in Franklin Templeton Etf Tr genomic adv etf with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Franklin Templeton Etf Tr genomic adv etf stock
Who bought or sold Franklin Templeton Etf Tr genomic adv etf this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Glenview Trust | 42k | $1.3M | 100% | Dec 2023 |
|
| Jane Street | 14k | $455k | -46% | Mar 2024 |
|
| Gts Securities | 14k | $449k | -72% | Mar 2024 |
|
| Citadel Advisors | 11k | $363k | 100% | Mar 2024 |
|
| LPL Financial | 9.2k | $303k | 1% | Mar 2024 |
|
| Commonwealth Equity Services | 7.0k | $231k | 0% | Mar 2024 |
|
| Susquehanna International | 6.9k | $227k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 297.00 | $9.7k | -25% | Mar 2024 |
|
| Harbour Investments | 188.00 | $5.7k | 0% | Dec 2023 |
|
| Citigroup | 15.00 | $490.999500 | 100% | Mar 2024 |
|
Who sold out of Franklin Templeton Etf Tr genomic adv etf?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2023 | 1.6k | $50k |